Introduction 5 5
Timely and accurate drug susceptibility testing (DST) of M. tuberculosis isolates is vital to irreproducible DST results (n = 1), no growth in the 7H10 agar dilution assay (n = 3), 1 0 0 duplication (n = 1), mixed cultures (n = 2, cross-contamination or patient infected with 1 0 1 multiple strains) or transmission clusters (n = 2). The final set consisted of 176 strains. MGIT 960-and 7H10 agar dilution-based phenotypic DST were performed as described 1 0 4 previously [14] . Table 1 The categorical agreement between the MIC determination by MGIT 960 and 7H10 agar 1 1 0 dilution was determined based on the ECOFFS (Table 1) .
The numerical variation between the two methods was quantified as the geometric standard 1 1 2 deviation (SD, given with its standard error) of the ratio MIC MGIT 960/MIC agar dilution, implemented in the R package fitdistrplus (v.1.0-9) [19] . If the data was compatible with σ = 1 1 6 0, the geometric standard deviation could not be estimated and was defined as "not 1 1 7 applicable" (NA). The approach is a generalization of the Bland and Altman method [20], 1 1 8 taking censoring of the data into account. Strains for which the MGIT 960 MIC and 7H10 1 1 9 agar dilution MIC were both left-censored or both right-censored were excluded since no 1 2 0 information on the ratio could be derived. Goodman and Kruskal's gamma was used to quantify the rank correlation between the two 1 2 2 methods. No correlation could be calculated if the variance for either method was 0 (NA). Distributions of wt and mutant MICs were analysed qualitatively based on the results of 1 2 4 7H10 agar dilution. We divided the dataset into two groups: drugs for which the MIC 1 2 5 distributions of wt and mutant strains did not overlap, and those for which MIC distributions Sensitivities and specificities of WGS-based resistance profile inference were calculated 1 2 8 based on the 7H10 agar dilution results for all drugs, except pyrazinamide -for which the 1 2 9
MGIT 960 results were used, based on resistance/susceptibility at the WHO-defined critical 1 3 0 concentrations and the presence or absence of a putative resistance-associated mutation. 
Defining clinical breakpoints for high/low-level resistance
The therapeutic window of a drug is defined as the maximal serum concentration which is ECOFF. For these, MIC increases caused by mutations may still be within the therapeutic 1 3 6 window of a drug: these strains might still be treatable by increasing the drug dose. We WGS and data analysis was performed as previously described [22] and summarised in the 1 4 2 supplementary materials. The performance of WGS-based DST greatly depends on the 1 4 3 7 availability of robust markers of resistance. We therefore focussed on a set of high-1 4 4 confidence resistance-associated genes [4, 12] (Table 2) . The strains showed a range of drug resistance profiles ( Figure 1 ). Based on the set of 1 6 6 analysed genes (Table 2) , 25 strains were predicted to be fully susceptible against all assayed 1 6 7 drugs, 59 strains were mono-/poly-resistant, 91 strains demonstrated MDR phenotypes and After exclusion of known phylogenetic markers not involved in resistance, WGS-based 1 7 2 prediction of drug resistance using a defined set of target genes ( (Table 3 and Figure 2 ). Based on the in silico resistance prediction, the MICs of mutant and 1 7 5 wt strains frequently followed a Gaussian distribution. However, the same resistance marker S8C, S9C, S10C). In some cases, the increase in the MIC conferred by a certain resistance 1 7 8 mutation fell within the distribution the of wt MIC (e.g. for gidB, eis promotor mutations, The overlap in MIC distributions between wt and strains carrying an embB mutation was 1 9 5 reduced by adjusting the critical concentration for ethambutol resistance from 5 mg/L to 2.5 1 9 6 mg/L (MGIT 960). However, there was variability in the MICs for the same mutation (e.g. MIC EmbB M306I/V in 7H10 agar dilution: 4-16 mg/L -supplementary Figure S2C ). Moxifloxacin resistance was rare (n = 9, MGIT 960, critical concentration 0.25 mg/L) and MIC distributions of mutant strains partially overlapped with those of wt. Sensitivity of the 2 0 0 genome-based moxifloxacin resistance prediction was 80.0% (Table 4 ). Most mutations in rpoB increased the MIC for rifamycins beyond the therapeutic window 2 1 1 (peak serum concentration 10 mg/L [21, 23]). However, some rare rpoB mutations (e.g. MGIT 960/7H10 agar dilution, respectively. Mutations in rpoB conferring resistance to rifampicin and rifabutin showed highly correlated mg/L for MGIT 960/7H10 agar dilution) amikacin resistance may be warranted. were common and produced a range of different MICs. However, there were mutations that 2 3 6 systematically lead to MICs beyond the therapeutic window, e.g. RpsL K43R. Defining low- WGS, we were able to define CBC for high-and low-level resistance for isoniazid, Our data suggest that the current WHO-defined critical concentration for phenotypic DST of The mutations identified by WGS had a high predictive power to classify strains as resistant. However, the predictive power depends on a number of factors. For instance, the increase in MIC conferred by an identical resistance mutation can vary greatly in different strains (e.g. EmbB M306I/V, RpsL K88R). Such variation is clinically relevant if there is a significant 2 6 0 overlap between the MICs of mutant and wt strains, as was the case for ethionamide, 2 6 1 ethambutol and streptomycin (e.g. gidB) resistance mutations. Furthermore, it is difficult to window of a drug. The overlap between MICs of mutant and wt strains is confounded by the 2 6 4 fact that we only screened for mutations in genes which had previously been associated with 2 6 5 drug resistance. We might thus have missed possible resistance-confering mutations in other 2 6 6 genes. Additionally, WGS will always produce distributions of coverages which in term will 2 6 7 inevitably lead to certain regions in the genome suffering from low coverage, preventing the 2 6 8 detection of mutations. The inability to call mutations due to low coverage will therefore lead 2 6 9 to false negatives, reducing sensitivity. Furthermore, the strain genetic background [24], non- The predictive power of mutations in target genes also depends on removing phylogenetic 2 7 4 markers not involved in resistance. Separating phylogenetic from resistance-associated 2 7 5 markers works well for essential (highly conserved) genes such as rpoB, rpsL, rrs but is 2 7 6 problematic in non-essential genes involved in the conversion of prodrugs into their active 2 7 7 forms like pncA (pyrazinamide), ethA (ethionamide) or in genes that generally exhibit higher 2 7 8 numbers of polymorphisms e.g. embB. Of note, the embABC operon is highly polymorphic, [27] will therefore inevitably evolve in the presence of phylogenetic SNPs and may interact 2 8 2 epistatically to produce the variability in MICs we observed for wt strains and for the most Similarly, in the case of streptomycin resistance, the RpsL substitution K88R exhibited a 2 9 3 range in MICs from low to high-level resistance making it difficult to judge the susceptibility 2 9 4 of a strain harbouring this mutation based on the genotype. Streptomycin was the first use has produced complex resistance profiles with multiple streptomycin resistance mutations 2 9 7 (e.g. in gidB, rpsL, rrs) occurring concomitantly, producing wide ranges of MICs.
Agreement between MGIT 960 and 7H10 agar dilution phenotypic DST

9 8
Furthermore, many streptomycin resistant strains displayed MDR/XDR phenotypes. Streptomycin resistance mutations are frequently found in backgrounds which have mutations [30], considering that streptomycin is not part of the current standard treatment regimen and 3 0 8 selection for high-level streptomycin resistance is relaxed.
3 0 9
In conclusion, we demonstrate that MGIT 960 and 7H10 agar dilution-based phenotypic DST resistance-associated genes and rare resistance markers with low frequencies will likely be going studies will pave the way for the replacement of phenotypic DST with drug resistance 3 1 8
profile prediction based on WGS in the coming years. We would like to thank Alexandra Mushegian for critically reading the manuscript and 
